Danaher Corporation
DHR
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterizatioā¦ read more
Healthcare
Diagnostics & Research
47 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$166.26
Price-0.16%
-$0.26
1Y
Price
Market Cap
$117.674b
Large
Price/Earnings 3y Avg5y Avg
32.3x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+25.8%
EBITDA Margin+17.3%
Net Profit Margin+18.2%
Free Cash Flow Margin+25.8%
EBITDA Margin+17.3%
Net Profit Margin+18.2%
Free Cash Flow MarginRevenue
$24.778b
+0.9%
1y CAGR+1.2%
3y CAGR-1.7%
5y CAGREarnings
$3.689b
+2.1%
1y CAGR-7.8%
3y CAGR-14.3%
5y CAGREPS
$5.17
+2.6%
1y CAGR-6.4%
3y CAGR-13.3%
5y CAGRBook Value
$52.957b
$83.544b
Assets$30.595b
Liabilities$18.484b
DebtDebt to Assets
22.1%
2.8x
Debt to EBITDAFree Cash Flow
$5.291b
+0.6%
1y CAGR-2.8%
3y CAGR-7.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company